Epidemiologie psychischer Störungen

Kernaussagen

Während die deskriptive Epidemiologie sich u. a. mit Inzidenz- und Prävalenzraten, dem Verlauf sowie den sozioökonomischen Beeinträchtigungen durch psychische Erkrankungen befasst, will die analytische Epidemiologie die Kenntnis über Ursachen und Risikofaktoren erweitern. Zur Erreichung dieser Ziele kommen verschiedene Erfassungsmethoden zum Einsatz, z. B. Quer- oder Längsschnittuntersuchungen, Beobachtungsstudien und Risikoberechnungen.

Publication History

Publication Date:
06 September 2013 (online)

• Literatur

• 1 Kraemer HC, Kazdin AE, Offord DR. et al. Coming to terms with the terms of risk. Arch Gen Psychiat 1997; 54: 337-343
• 2 Hill SB. The Environment and disease: association or causation?. J R Soc Med 1965; 58: 295-300
• 3 Gordis L. Epidemiology. 4th. ed. Philadelphia: Elsevier/Saunders; 2009
• 4 Lieb R. Epidemiologie. In: Perrez M, Baumann U. Hrsg. Lehrbuch Klinische Psychologie – Psychotherapie. 4.. Aufl. Bern: Huber; 2011: 149-169
• 5 Susser E, Schwartz S, Morabia A, Bromet EJ. Psychiatric Epidemiology: Searching for the causes of mental disorders. New York: Oxford University Press; 2006
• 6 Höfler M. Statistik in der Epidemiologie psychischer Störungen. Berlin: Springer; 2004
• 7 Kessler RC, McLaughlin KA, Green JG. et al. Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. Brit J Psychiat 2010; 197: 378-385
• 8 Im Internet: Accessed June 18, 2013 at: http://www.hcp.med.harvard.edu/wmh/
• 9 Kessler RC, Üstün TB. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. Cambridge: Cambridge University Press; 2008
• 10 Im Internet: Accessed June 18, 2013 at: http://www.europeanbraincouncil.org/
• 11 Wittchen HU, Jacobi F, Rehm J. et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharm 2011; 21: 655-679
• 12 Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. Eur Neuropsychopharm 2005; 15: 357-376
• 13 Kessler RC, McGonagle KA, Zhao S. et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19
• 14 Kessler RC, Chiu WT, Demler O. et al. Prevalence, severity, and comorbidity of 12-month DSM-IV-disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627
• 15 Merikangas KR, He JP, Burstein M. et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Psy 2010; 49: 980-989
• 16 Wittchen HU, Nelson CB, Lachner G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 1998; 28: 109-126
• 17 Andrade L, Caraveo-Anduaga JJ, Berglund P. et al. Cross-sectional comparisons of the prevalences and correlates of mental disorders. Bull World Health Org 2000; 78: 413-428
• 18 Gustavsson A, Svensson M, Jacobi F. et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharm 2011; 21: 718-779
• 19 Alonso J, Petukhova M, Vilagut G. et al. Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Mol Psychiatr 2011; 16: 1234-1246